Industry litigation – Page 6
-
Business3M slashes 1500 jobs globally
Reduction adds to 2000 layoffs announced in April, and is intended to save the company $110–120 million annually
-
BusinessFrance to ban 36 glyphosate products by end of 2020
Move follows similar bans in several European states, with safety agency citing ‘absence of scientific data ruling out genotoxic risks’
-
OpinionWhen should employees share profits from inventions?
Glucose monitor inventor wins £2m payout from Unilever after claiming his work provided ’outstanding benefit’
-
BusinessPharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
BusinessFormer Braskem chief arrested in US for bribery
Ex-leader of Brazilian petrochemical firm allegedly helped divert $250m to a secret slush fund to bribe government officials and political parties
-
BusinessFormer Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo
-
OpinionIs bankruptcy best for Purdue?
Many would prefer to see the Sackler family held personally liable, and the company wound down
-
BusinessChemical firms urged to plan for no-deal Brexit
European Chemicals Agency highlights hundreds of chemicals whose Reach registrations would be voided
-
BusinessLandmark ruling in Oklahoma opioid lawsuit
J&J judged responsible for ‘public nuisance’ in first case to go to trial
-
BusinessUS judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
NewsPatient and research groups condemn draft bill allowing human gene patenting in US
A measure floated by Congress could hinder research and access to gene tests and raise their costs
-
OpinionIs Bayer regretting its Monsanto takeover?
Large damages in Roundup litigation have got investors questioning the move
-
BusinessJury awards $2bn damages in US glyphosate trial
Bayer vows to appeal third defeat over Monsanto’s Roundup weedkiller, while experts suggest damages will likely be reduced
-
BusinessEmerging from the US opioid crisis
With litigation against suppliers in full swing, how does the US counter its addiction to powerful painkillers?
-
OpinionShow me the data
Making industrial safety research more transparent benefits both companies and consumers
-
NewsWhy jury verdicts get overruled in US industry cancer trials
Judges often end up intervening post-trial in complex cases with conflicting scientific evidence
-
BusinessDowDuPont ends fungicide dog experiment amid public pressure
Brazil agrees regulatory waiver for ‘unnecessary’ experiment highlighted in US Humane Society undercover footage
-
NewsUniversity sues professor for taking graduate’s research that he stands to make millions from
University of Missouri–Kansas City pharmacy researcher accused of stealing inventions related to a novel eye drug delivery formulation, sold it for $1.5m plus royalties
-
OpinionDivergent reality
If the UK leaves the EU without a deal, the two will inevitably drift further apart
-
BusinessWhat might Brexit mean for industry?
Questions hang over regulation, trade, talent and investment